IGFBP7 expression is low in glioblastoma, lung cancer, pancreatic cancer and liver cancer [6], [9], [10], [13], while both increased and decreased expression of IGFBP7 have been reported in breast and prostate cancer [14]–[17]. Here, IGFBP7 is linked to prostate cancer.